Guest Lecture on “Translational Research in Pharmaceutical Sciences” & Faculty Interaction held at SPS

Published on: April 3, 2026

The School of Pharmaceutical Sciences (SPS), Swami Rama Himalayan University (SRHU), Dehradun (Jolly Grant), organized an insightful guest lecture by Dr. Deepak Kumar Rathore (PhD), Senior Research Scientist, THSTI, Faridabad on 3rd April at the B.C. Roy Auditorium. The theme of the lecture was Translational Research in Pharmaceutical Sciences, aimed at providing students and faculty with a deeper understanding of how laboratory research can be translated into real-world solutions. The program commenced with a warm welcome of Dr. Rathore. A welcome was extended as a token of respect and appreciation by Prof. Ganesh, marking a gracious beginning to the session.

Dr. Rathore delivered an engaging and informative lecture highlighting the concept of translational research, emphasizing how scientific discoveries can be transformed into practical applications for community benefit. He illustrated this effectively with the example of the COVID-19 vaccine, explaining its immunological response and how rapid research translation significantly benefited public health. He further elaborated on the role of the Translational Health Science and Technology Institute (THSTI) in bridging the gap between basic research and clinical application. He also guided students on how to enter the research field, the required skill sets, and the long-term benefits of pursuing a career in translational research.

The session was followed by an interactive question-and-answer session, where students actively participated and raised various queries related to research, immunology, and career opportunities. Dr. Rathore addressed all questions comprehensively, motivating students and providing valuable insights into the research ecosystem. The program concluded with a vote of thanks delivered by the Dean, SPS, who appreciated the valuable insights shared by Dr. Rathore. She also encouraged and motivated students to actively engage in such academic sessions, highlighting the importance of learning from eminent scientists and developing a strong listening and research-oriented approach.

Post tea break, a faculty interaction session was held in the Dean’s office. Dr. Rathore discussed various funding opportunities and shared strategies on how to secure research grants with faculty of School of Pharmaceutical Sciences. He also highlighted how THSTI can support institutions in obtaining funding for international conferences as well as collaborative research projects. Faculty members introduced themselves and presented their ongoing research work. Dr. Rathore encouraged faculty members to strengthen their research activities and emphasized the importance of establishing research excellence laboratories to enhance the chances of securing extramural funding from agencies such as ICMR, DST, and ANRF.

Overall, the event was a great success and significantly contributed to fostering a research-driven academic environment within the institution.

1 sps
2sps
3sps
4sps
   Admissions Form         

Admission Open For 2025

×
International Endowed Chair Professor

Prof Rakesh Kumar

Prof Rakesh Kumar is the Founder and President of the Breast Cancer in Young Women Foundation (USA), dedicated to vaddressing the distinct issues affecting young women with breast cancer. He also serves as the International Endowed Chair Professor at the Cancer Research Institute of the Himalayan Institute of Medical Sciences. Additionally, he holds adjunct professorships at Rutgers New Jersey Medical School and Virginia Commonwealth University.

Dr Kumar earned his Ph.D. from the All India Institute of Medical Sciences in 1984 and began his research career at Memorial Sloan Kettering Cancer Center in January 1986. From 1988 to 2017, he held various academic and leadership positions —including faculty member, tenured professor, distinguished professor, endowed chair, department chair, and research leader—at esteemed institutions such as Memorial Sloan Kettering Cancer Center in New York and the University of Texas MD Anderson Cancer Center in Houston. From 2017 to 2022, he served as the National Chair for Cancer Research for the Government of India and as a distinguished professor, continuing his innovative work in breast cancer research.

With nearly 40 years of research and professional experience, Dr. Kumar has made conceptual contributions to the field of cancer research (h-index 108, citations >50,000). He has authored over 325 peer-reviewed publications, edited or co-edited nine books, and delivered 290 invited lectures worldwide. His work has been featured on the covers of 18 major cancer journals and has been highlighted in institutional research reports of the MD Anderson Cancer Center.

A passionate educator and mentor, Dr. Kumar has guided 67 trainees throughout his career. He serves on the editorial boards of multiple leading cancer journals and has served on the editorial boards of 21 top cancer journals. His global reputation is further demonstrated by his participation in about 100 peer-review panels for cancer research funding in the US and internationally over the past 28 years.

Dr. Kumar's innovative research has earned him numerous prestigious honors, including the Hinkle Society Faculty Award at Penn State University (1994), the Dalla/Fort Worth Living Legend Faculty Achievement Award in Basic Sciences (2004), the Ranbaxy Research Award (2006), and the Lifetime Achievement Award from the American Association of Indian Scientists in Cancer Research (2013), among others. Dr. Kumar's pioneering research continues to have a profound influence on the fields of oncology and breast cancer, opening up new opportunities for biomedical scientists and trainees worldwide.